Predicting Dementia Risk: Progress, Pitfalls, and Priorities

As populations age, identifying individuals at high risk for dementia has become a cornerstone of prevention-oriented public health policy. Accurate and scalable risk stratification could enable early intervention and resource targeting. However, existing models face methodological limitations, including constraints in available data and follow-up duration, challenges in dementia ascertainment, heterogeneity in modelling approaches, and limited external validation. This commentary discusses these challenges and identifies methodological priorities for developing dementia risk algorithms that are robust and suitable for real-world implementation.Existing longitudinal datasets exhibit significant limitations in diversity and temporal scope. Most prediction models use cohorts from high-income countries which constrains generalizability. Moreover, most datasets, except for a few multi-decade cohorts such as the Whitehall II study, have follow-up periods that are too short to capture life-course risk trajectories. [1] These limitations are further compounded by heterogeneity in study designs [2] which hampers comparisons across cohorts and algorithms. Selection bias further compromises representativeness as volunteer-based cohorts may underrepresent vulnerable populations with limited healthcare access, raising concerns about the generalizability of these algorithms across diverse populations and healthcare settings.The establishment of dementia diagnosis is a necessary step for risk prediction; however, dementia ascertainment varies substantially across contexts. Community-based diagnoses captured through billing codes in administrative data often occur at advanced stages of disease, reflecting delayed provider recognition and variability in access to healthcare.[3] Research cohorts, such as the UK Biobank, employ regular cognitive assessments to identify cases, and may detect dementia early. However, they rely on participant-reported diagnoses between assessment waves, potentially introducing recall bias and misclassification. [2, 4] More in-depth ascertainment of dementia status, such as interviews conducted by trained research personal, [2, 4] may not be feasible in non-specialist clinical settings. In addition, even within similar datasets, investigators employ varying outcome definitions, from composite cognitive measures to single diagnostic codes, limiting direct comparison of model performance. [1,5] Current algorithm development exhibits substantial methodological diversity. Most studies conduct only internal validation through sample splitting,[4] with unstandardized partitioning procedures and performance metrics. Additionally, methods used to develop risk stratification algorithms vary, reflecting the heterogeneity across data sources.